Shared Causal Paths underlying Alzheimer’s dementia and Type 2 Diabetes

被引:0
|
作者
Zixin Hu
Rong Jiao
Panpan Wang
Yun Zhu
Jinying Zhao
Phil De Jager
David A. Bennett
Li Jin
Momiao Xiong
机构
[1] State Key Laboratory of Genetic Engineering and Innovation Center of Genetics and Development,Department of Epidemiology
[2] School of Life Sciences,undefined
[3] Fudan University,undefined
[4] Department of Biostatistics and Data Science,undefined
[5] School of Public Health,undefined
[6] University of Texas Health Science Center at Houston,undefined
[7] Human Phenome Institute,undefined
[8] Fudan University,undefined
[9] University of Florida,undefined
[10] Center for Translational & Computational Neuroimmunology,undefined
[11] Department of Neurology,undefined
[12] Columbia University Medical Center,undefined
[13] Rush Alzheimer’s Disease Center,undefined
[14] Rush University Medical Center,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Although Alzheimer’s disease (AD) is a central nervous system disease and type 2 diabetes MELLITUS (T2DM) is a metabolic disorder, an increasing number of genetic epidemiological studies show clear link between AD and T2DM. The current approach to uncovering the shared pathways between AD and T2DM involves association analysis; however such analyses lack power to discover the mechanisms of the diseases. As an alternative, we developed novel causal inference methods for genetic studies of AD and T2DM and pipelines for systematic multi-omic casual analysis to infer multilevel omics causal networks for the discovery of common paths from genetic variants to AD and T2DM. The proposed pipelines were applied to 448 individuals from the ROSMAP Project. We identified 13 shared causal genes, 16 shared causal pathways between AD and T2DM, and 754 gene expression and 101 gene methylation nodes that were connected to both AD and T2DM in multi-omics causal networks.
引用
下载
收藏
相关论文
共 50 条
  • [31] Common Cellular and Molecular Mechanisms Underlying Alzheimer's Disease and Type 2 Diabetes: A Knowledge-Driven Approach
    Gauthaman, Kalamegam
    Pushparaj, Peter Natesan
    Rajeshkumar, Manoharan
    Narasimhan, Kothandaraman
    Al-Qahtani, Mohammed
    Cheung, Nam Sang
    Manikandan, Jayapal
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (02) : 247 - 258
  • [32] Alzheimer's type dementia in women - Reply
    Nedoschill, JC
    Lanczik, M
    Lang, CJG
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2000, 68 (05) : 241 - 242
  • [33] Neuropsychological subgroups of dementia of the Alzheimer's type
    Williams, RN
    McIntosh, DE
    Eells, GT
    Dean, RS
    Hendrie, H
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1996, 87 (1-2) : 79 - 90
  • [34] Neurobehavioral disorders in Alzheimer's dementia type
    Canas-Lucendo, Manuel
    Perea-Bartolom, Victoria
    Ladera-Fernandez, Valentina
    TERAPIA PSICOLOGICA, 2020, 38 (02): : 223 - 242
  • [35] Small test for dementia of Alzheimer's type
    Kashima, Haruo
    PSYCHOGERIATRICS, 2007, 7 (01) : 1 - 3
  • [36] Aripiprazole in dementia of the Alzheimer's type.
    Jeste, DV
    De Deyn, P
    Carson, W
    Marcus, R
    McQuade, RD
    Schneider, L
    Mintzer, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S226 - S226
  • [37] Coverbal gestures in Alzheimer's type dementia
    Carlomagno, S
    Pandolfi, M
    Marini, A
    Di Iasi, G
    Cristilli, C
    CORTEX, 2005, 41 (04) : 535 - 546
  • [38] Dysgraphia in mild dementia of Alzheimer's type
    Hughes, JC
    Graham, N
    Patterson, K
    Hodges, JR
    NEUROPSYCHOLOGIA, 1997, 35 (04) : 533 - 545
  • [39] Phenomenology of psychosis in dementia of Alzheimer's type
    Sobow, T
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 99 - 99
  • [40] Driving retirement in dementia of the Alzheimer's type
    Carr, DB
    NEUROBIOLOGY OF AGING, 2004, 25 : S320 - S320